(1986). Altman DG: Statistical-Methods For Assessing Agreement Between 2 Methods Of Clinical Measurement. Lancet
(1991). Cell-Mediated Cytotoxicity Against U-937 Cells By Human Monocytes And Macrophages In A Modified Colorimetric Mtt Assay - A Methodological Study.
(2009). Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
(2002). Cellular and molecular aspects of drugs of the future: oxaliplatin. Cell Mol Life Sci
(2009). Cytotoxic activity and cellular processing in human ovarian carcinoma cell lines of a new platinum(II) compound containing a fluorescent substituted propylene diamine ligand. Biochem Pharmacol
(1996). Darling JL: Assay of anticancer drugs in tissue culture: Comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma. Anti-Cancer Drugs
(2002). DI: In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer.
(1987). Neubauer RH: Semiautomated Colorimetric Assay For Invitro Screening Of Anticancer Compounds. Cancer Treatment Reports
(2003). New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
(1999). Peters GJ: Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
(1992). Prediction Of Response To Drug-Therapy Of Cancer - A Review Of Invitro Assays. Drugs
(1986). Rapid Colorimetric Assay For Cell-Growth And Survival - Modifications To The Tetrazolium Dye Procedure Giving Improved Sensitivity And Reliability. J Immunol Methods
(1983). Rapid Colorimetric Assay For Cellular Growth And Survival - Application To Proliferation And Cyto-Toxicity Assays. J Immunol Methods
(1989). SB: Effects Of The Ph-Dependence Of 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyl-Tetrazolium Bromide-Formazan Absorption On Chemosensitivity Determined By A Novel TetrazoliumBased Assay. Cancer Res
(1989). Scudiero N: Evaluation of colorimetric protein and biomass stains for assaying in vitro drug effects upon human tumor cell lines. Proc Am Assoc Cancer
(2004). SS: Inhibitory effects of phaseolotoxin on proliferation of leukemia cells HL-60, K-562 and L1210 and pancreatic cells RIN-m5F. Leuk Res
(1989). Status of the NCI preclinical antitumor drug discovery screen. Princ Pract Oncol
(1991). Use Of An Aqueous Soluble Tetrazolium Formazan Assay For Cell-Growth Assays In Culture. Cancer Communications